Genenta Science (ADR) (GNTA)
Develops tumor-targeted gene therapy and staged Italian defense and aerospace investments.
$0.6877
vs last close−0.02 (−2.32%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Apr '23Jun '23Oct '23Apr '24Jun '24Oct '24Oct '25Mar '26
Reported−$0.38−$0.40−$0.40−$0.30−$0.24−$0.31−$0.42−$0.36
Estimate—−$0.41−$0.41−$0.42——−$0.45−$0.36
Surprise—+3.2%+2.6%+29.7%——+5.3%0.0%
RevenueReportedEstimate
Apr '23Jun '23Oct '23Apr '24Jun '24Oct '24Oct '25Mar '26
Reported———$5.5M————
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2027 | −$0.26 | — | — |
| Sep 2026 | −$0.27 | — | — |
| Mar 2026 | −$0.36 | −$0.36 | 0.0% |
| Oct 2025 | −$0.45 | −$0.42 | +5.3% |
| Mar 2025 | −$0.26 | — | — |
| Oct 2024 | — | −$0.31 | — |
| Jun 2024 | — | −$0.24 | — |
| Apr 2024 | |||
| Oct 2023 | |||
| Jun 2023 | |||
| Apr 2023 | |||
| Oct 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 3, 2027 | −$0.26 | — | — | — | — | — | — |
| Sep 2, 2026 | −$0.27 | — | — | — | — | — | — |
| Mar 31, 2026 | −$0.36 | −$0.36 | 0.0% | — | — | — | +6.7% |
| Oct 10, 2025 | −$0.45 | −$0.42 | +5.3% | — | — | — | +6.8% |
| Mar 28, 2025 | −$0.26 | — | — | — | — | — | — |
| Oct 29, 2024 | — | −$0.31 | — | — | — | — | −0.2% |
| Jun 30, 2024 | — | −$0.24 | — | — | — | — | −0.7% |
| Apr 24, 2024 | |||||||
| Oct 20, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Oct 7, 2022 | |||||||
| May 4, 2022 | |||||||
| Dec 15, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 |